BioTelemetry soars 18% after Philips announces acquisition of cardiac-diagnostics company
- BioTelemetry gained as much as 18% on Friday after news that the cardiac-diagnostics company will be acquired by Dutch company
Royal Philipsfor $2.8 billion.
- Shares of
BioTelemetryrose from Thursday's $61.78 closing price to as much as $73 on Friday, the stock's highest price in over a year.
- BioTelemetry is a Pennsylvania-based medical company that makes equipment that remotely diagnoses and monitors cardiac activity.
- Watch BioTelemetry trade live here.
BioTelemetry gained as much as 18% on Friday after news that the cardiac-diagnostics firm will be acquired by Dutch company Royal
"Through continued innovation, we have developed the world's largest remote cardiac monitoring services network," said BioTelemetry President and CEO Joseph H. Capper in a statement. "Combined with Philips' current patient care management portfolio, innovation strength and global scale, we are perfectly equipped to address the rising demand for telehealth and remote monitoring solutions."Shareholders of BioTelemetry will receive $72 a share in cash, according to Philips. The transaction is expected to be completed in the first quarter of 2021.
- SBI, HDFC, ICICI and 12 others banks are joining forces to use blockchain to power Letters of Credit — a move that could be a boon for MSMEs
- Larsen & Toubro Infotech to buy Pune-based digital engineering firm CueLogic
- Canadian edtech unicorn ApplyBoard to 'step up' growth in India, raises $300 million in external investment
- Best 43-inch smart LED TVs for small and medium sized rooms
- Moderna's protein-based Covid jab and mRNA vaccine safe for use in children, says university study